TY - JOUR
T1 - Pathophysiology of Contrast-Induced Acute Kidney Injury
AU - Bansal, Shweta
AU - Patel, Rahul N.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/7
Y1 - 2020/7
N2 - Passing contrast media through the renal vascular bed leads to vasoconstriction. The perfusion decrease leads to ischemia of tubular cells. Through ischemia and direct toxicity to renal tubular cells, reactive oxygen species formation is increased, enhancing the effect of vasoconstrictive mediators and decreasing the bioavailability of vasodilative mediators. Reactive oxygen species formation leads to oxidative damage to tubular cells. These interacting pathways lead to tubular necrosis. In the pathophysiology of contrast-induced acute kidney injury, low osmolar and iso-osmolar agents have theoretic advantages and disadvantages; however, clinically the difference in incidence of contrast-induced acute kidney injury has not changed.
AB - Passing contrast media through the renal vascular bed leads to vasoconstriction. The perfusion decrease leads to ischemia of tubular cells. Through ischemia and direct toxicity to renal tubular cells, reactive oxygen species formation is increased, enhancing the effect of vasoconstrictive mediators and decreasing the bioavailability of vasodilative mediators. Reactive oxygen species formation leads to oxidative damage to tubular cells. These interacting pathways lead to tubular necrosis. In the pathophysiology of contrast-induced acute kidney injury, low osmolar and iso-osmolar agents have theoretic advantages and disadvantages; however, clinically the difference in incidence of contrast-induced acute kidney injury has not changed.
KW - Contrast media adverse effects
KW - Contrast media toxicity
KW - Contrast-associated acute kidney injury
KW - Contrast-induced acute kidney injury
KW - Contrast-induced nephropathy
UR - http://www.scopus.com/inward/record.url?scp=85084507570&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084507570&partnerID=8YFLogxK
U2 - 10.1016/j.iccl.2020.03.001
DO - 10.1016/j.iccl.2020.03.001
M3 - Review article
C2 - 32471670
AN - SCOPUS:85084507570
SN - 2211-7458
VL - 9
SP - 293
EP - 298
JO - Interventional Cardiology Clinics
JF - Interventional Cardiology Clinics
IS - 3
ER -